Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07487844 · ClinicalTrials.gov registry record · NA
Pulsed Electric Field Ablation for Metastatic Breast Cancer
A NA study, sponsored by University of California, San Francisco.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07487844 is a NA study that has not yet begun recruiting, run by University of California, San Francisco. The registered enrollment target is 20 participants.
The verdict
NCT07487844, a NA study, has not yet begun recruiting, sponsored by University of California, San Francisco.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a phase I trial of the safety of image-guided pulsed electric field (PEF) ablation for the locoregional treatment of superficial soft tissue lesions in adults with metastatic breast cancer using the AliyaTM Pulsed Electric Field System.
Interventions
- BEHAVIORAL Questionnaires
- DEVICE Pulsed Electric Field (PEF) System
- PROCEDURE Tumor Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-08-15 |
| Est. Completion | 2028-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07487844
The ClinicalTrials.gov registry entry for NCT07487844 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Questionnaires is the first listed.
NCT07487844 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07487844 about?
NCT07487844 is a clinical study titled "Pulsed Electric Field Ablation for Metastatic Breast Cancer". This is a phase I trial of the safety of image-guided pulsed electric field (PEF) ablation for the locoregional treatment of superficial soft tissue lesions in adults with metastatic breast cancer using the AliyaTM Pulsed Electric Field System.
What is the current status of trial NCT07487844?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-08-15. Estimated completion is 2028-08-01.
What interventions are being tested in trial NCT07487844?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Pulsed Electric Field (PEF) System (DEVICE), Tumor Ablation (PROCEDURE).
Who is sponsoring clinical trial NCT07487844?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.